Basic Information
RNALocate ID: RLID:01001478
RNA Symbol: hsa-miR-107
Localization: Cytoplasm
RNA Information
RNA Name: hsa-miR-107
RNA ID: miRBase:MIMAT0000104
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21695135
Tissue/Cell Line: Cell line (HeLa)
Method: Microarray

Heatmap showing the 57 miRNAs differentially expressed in HeLa cells from mitochondrial and cytosolic RNA. Three independent microarray profiling experiments (microarray n1, n2 and n3) are shown and reproducibly revealed 13 miRNAs enriched in mitochondrial RNA.

Originally published in PLoS One. Bandiera S, et al, 2011. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)
Description: While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001479 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001480 Mitochondrion HEK-293 cells|HeLa cells|Myotube 27396686
RLID:01001481 Mitochondrion HEK-293 cells|HeLa cells|Skeletal muscle cells 27563705
RLID:01001482 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001483 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001484 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001485 Nucleolus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001486 Nucleus Colon adenocarcinoma cells 20864815
RLID:11001046 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11001047 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001048 Exosome Brain tissue 23382797
RLID:11001049 Exosome Plasma 23663360
RLID:11001050 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001051 Exosome K562 cells 24460325
RLID:11001052 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11001053 Microvesicle Plasma 23077538
RLID:11001054 Microvesicle Seminal plasma 23539611
RLID:11001055 Microvesicle Hepatoma cells 23771658
RLID-D:11000303 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
RLID-D:11001162 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-107 Splenic marginal zone lymphoma MNDR-E-MI-03750
MNDR hsa-miR-107 Multiple sclerosis chronic progressive MNDR-E-MI-03751
MNDR hsa-miR-107 Oral squamous cell carcinoma MNDR-E-MI-03752
MNDR hsa-mir-107 Medulloblastoma MNDR-E-MI-03753
MNDR hsa-miR-107 High-grade serous ovarian carcinoma MNDR-E-MI-03754
MNDR hsa-miR-107 Ovarian clear cell carcinoma MNDR-E-MI-03755
MNDR hsa-miR-107 Uterine corpus endometrial carcinoma MNDR-E-MI-03756
MNDR hsa-miR-107 Lymphoma MNDR-E-MI-03757
MNDR hsa-miR-107 Lymphoma non-hodgkin MNDR-E-MI-03758
MNDR hsa-miR-107 Estrogen-receptor positive breast cancer MNDR-E-MI-03759
MNDR hsa-miR-107 Estrogen-receptor negative breast cancer MNDR-E-MI-03760
MNDR hsa-miR-107 Progesterone-receptor positive breast cancer MNDR-E-MI-03761
MNDR hsa-miR-107 Progesterone-receptor negative breast cancer MNDR-E-MI-03762
MNDR hsa-miR-107 Her2-receptor positive breast cancer MNDR-E-MI-03763
MNDR hsa-miR-107 Acute promyelocytic leukemia MNDR-E-MI-03764
MNDR hsa-mir-107 Acute promyelocytic leukemia MNDR-E-MI-03765
MNDR hsa-miR-107 Breast cancer luminal MNDR-E-MI-03766
MNDR hsa-miR-107 Anencephaly MNDR-E-MI-03767
MNDR hsa-mir-107 Miyoshi myopathy MNDR-E-MI-03768
MNDR hsa-mir-107 Muscular disease MNDR-E-MI-03769
MNDR hsa-miR-107 Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-03770
MNDR hsa-mir-107 Colorectal carcinoma MNDR-E-MI-03771
MNDR hsa-mir-107 Autosomal recessive limb-girdle muscular dystrophy type 2a MNDR-E-MI-03772
MNDR hsa-mir-107 Autosomal recessive limb-girdle muscular dystrophy type 2b MNDR-E-MI-03773
MNDR hsa-mir-107 Myopathy nemaline 3 MNDR-E-MI-03774
MNDR hsa-mir-107 Melanoma and neural system tumor syndrome MNDR-E-MI-03775
MNDR hsa-mir-107 Prostate cancer MNDR-E-MI-03776
MNDR hsa-miR-107 Prostate cancer MNDR-E-MI-03777
MNDR hsa-mir-107 Prostate carcinoma MNDR-E-MI-03778
MNDR hsa-mir-107 Chronic lymphocytic leukemia MNDR-E-MI-03779
MNDR hsa-miR-107 Hirschsprung disease MNDR-E-MI-03780
MNDR hsa-mir-107 Gastric cancer MNDR-E-MI-03781
MNDR hsa-miR-107 Gastric cancer MNDR-E-MI-03782
MNDR hsa-miR-107 Gastric lymphoma MNDR-E-MI-03783
MNDR hsa-mir-107 Alzheimer disease MNDR-E-MI-03784
MNDR hsa-miR-107 Alzheimer disease MNDR-E-MI-03785
MNDR hsa-mir-107 Sickle cell diseases MNDR-E-MI-03786
MNDR hsa-miR-107 Intracranial aneurysm MNDR-E-MI-03787
MNDR hsa-mir-107 Urinary bladder cancer MNDR-E-MI-03788
MNDR hsa-miR-107 Dysautonomia familial MNDR-E-MI-03789
MNDR hsa-mir-107 Distal muscular dystrophy MNDR-E-MI-03790
MNDR hsa-mir-107 Myotonic dystrophy MNDR-E-MI-03791
MNDR hsa-mir-107 Muscular dystrophy limb-girdle type 2a MNDR-E-MI-03792
MNDR hsa-mir-107 Muscular dystrophy limb-girdle type 2b MNDR-E-MI-03793
MNDR hsa-mir-107 Head and neck neoplasms MNDR-E-MI-03794
MNDR hsa-mir-107 Leukemia MNDR-E-MI-03795
MNDR hsa-miR-107 Leukemia MNDR-E-MI-03796
MNDR hsa-mir-107 Leiomyoma MNDR-E-MI-03797
MNDR hsa-miR-107 Huntington disease MNDR-E-MI-03798
MNDR hsa-miR-107 Chorea MNDR-E-MI-03799
MNDR hsa-miR-107 Cardiovascular disease MNDR-E-MI-03800
MNDR hsa-mir-107 Cardiomyopathy dilated MNDR-E-MI-03801
MNDR hsa-miR-107 Carotid stenosis MNDR-E-MI-03802
MNDR hsa-miR-107 Moyamoya disease MNDR-E-MI-03803
MNDR hsa-mir-107 Lung cancer MNDR-E-MI-03804
MNDR hsa-miR-107 Lung cancer MNDR-E-MI-03805
MNDR hsa-miR-107 Down syndrome MNDR-E-MI-03806
MNDR hsa-miR-107 Parkinson disease MNDR-E-MI-03807
MNDR hsa-miR-107 Major depressive disorder MNDR-E-MI-03808
MNDR hsa-miR-107 Basal-like breast cancer MNDR-E-MI-03809
MNDR hsa-mir-107 Breast cancer MNDR-E-MI-03810
MNDR hsa-mir-107 Cancer MNDR-E-MI-03811
MNDR hsa-mir-107 Squamous cell carcinoma MNDR-E-MI-03812
MNDR hsa-mir-107 Pituitary neoplasms MNDR-E-MI-03813
MNDR hsa-miR-107 Pituitary neoplasms MNDR-E-MI-03814
MNDR hsa-mir-107 Pancreatic cancer MNDR-E-MI-03815
MNDR hsa-miR-107 Pancreatic cancer MNDR-E-MI-03816
MNDR hsa-mir-107 Hepatitis c virus infection MNDR-E-MI-03817
MNDR hsa-miR-107 Melanoma MNDR-E-MI-03818
MNDR hsa-mir-107 Melanoma MNDR-E-MI-03819
MNDR hsa-miR-107 Rectum adenocarcinoma MNDR-E-MI-03820
MNDR hsa-mir-107 Colon cancer MNDR-E-MI-03821
MNDR hsa-miR-107 Colon cancer MNDR-E-MI-03822
MNDR hsa-mir-107 Syndrome MNDR-E-MI-03823
MNDR hsa-miR-107 Colon adenocarcinoma MNDR-E-MI-03824
MNDR hsa-mir-107 Multiple sclerosis relapsing-remitting MNDR-E-MI-03825
MNDR hsa-miR-107 Relapsing-remitting multiple sclerosis MNDR-E-MI-03826
MNDR hsa-miR-107 Familial ovarian cancer MNDR-E-MI-03827
MNDR hsa-mir-107 Ovarian cancer MNDR-E-MI-03828
MNDR hsa-miR-107 Prostate adenocarcinoma MNDR-E-MI-03829
MNDR hsa-miR-107 Kidney cancer MNDR-E-MI-03830
MNDR hsa-miR-107 Carcinoma ductal breast MNDR-E-MI-03831
MNDR hsa-miR-107 Acute kidney injury MNDR-E-MI-03832
MNDR hsa-mir-107 Glioblastoma MNDR-E-MI-03833
MNDR hsa-miR-107 Glioblastoma MNDR-E-MI-03834
MNDR hsa-mir-107 Glioblastoma multiforme somatic MNDR-E-MI-03835
MNDR hsa-miR-107 Astrocytoma MNDR-E-MI-03836
MNDR hsa-mir-107 Astrocytoma MNDR-E-MI-03837
MNDR hsa-mir-107 Glioma MNDR-E-MI-03838
MNDR hsa-miR-107 Glioma MNDR-E-MI-03839
MNDR hsa-mir-107 Gastrointestinal neoplasms MNDR-E-MI-03840
MNDR hsa-mir-107 Nemaline myopathy MNDR-E-MI-03841
MNDR hsa-miR-107 Chordoma MNDR-E-MI-03842
MNDR hsa-miR-107 Amyotrophic lateral sclerosis MNDR-E-MI-03843
MNDR hsa-miR-107 Osteosarcoma MNDR-E-MI-03844
MNDR hsa-mir-107 Osteosarcoma MNDR-E-MI-03845
MNDR hsa-miR-107 Liposarcoma MNDR-E-MI-03846
MNDR hsa-miR-107 Inclusion body myositis MNDR-E-MI-03847
MNDR hsa-miR-107 Pancreatic ductal adenocarcinoma MNDR-E-MI-03848
MNDR hsa-mir-107 Pancreatic ductal adenocarcinoma MNDR-E-MI-03849
MNDR hsa-miR-107 Anterior cerebral artery infarction MNDR-E-MI-03850
MNDR hsa-miR-107 Liver cancer MNDR-E-MI-03851
MNDR hsa-miR-107 Cervical adenocarcinoma MNDR-E-MI-03852
MNDR hsa-miR-107 Gastric adenocarcinoma MNDR-E-MI-03853
MNDR hsa-miR-107 Posterior cerebral artery infarction MNDR-E-MI-03854
MNDR hsa-miR-107 Pituitary adenoma MNDR-E-MI-03855
MNDR hsa-mir-107 Pituitary adenoma MNDR-E-MI-03856
MNDR hsa-miR-107 Lung squamous cell carcinoma MNDR-E-MI-03857
MNDR hsa-miR-107 Carcinoma lung non-small-cell MNDR-E-MI-03858
MNDR hsa-mir-107 Carcinoma lung non-small-cell MNDR-E-MI-03859
MNDR hsa-miR-107 Lung adenocarcinoma MNDR-E-MI-03860
MNDR hsa-miR-107 Adrenocortical carcinoma MNDR-E-MI-03861
MNDR hsa-miR-107 Ovarian carcinoma MNDR-E-MI-03862
MNDR hsa-mir-107 Pancreatic adenocarcinoma MNDR-E-MI-03863
MNDR hsa-miR-107 Pancreatic adenocarcinoma MNDR-E-MI-03864
MNDR hsa-miR-107 Myasthenia gravis autoimmune experimental MNDR-E-MI-03865
MNDR hsa-miR-107 Carcinoma renal cell MNDR-E-MI-03866
MNDR hsa-miR-107 Kidney renal papillary cell carcinoma MNDR-E-MI-03867
MNDR hsa-miR-107 Renal clear cell carcinoma MNDR-E-MI-03868
MNDR hsa-miR-107 Intrahepatic cholangiocarcinoma MNDR-E-MI-03869
MNDR hsa-mir-107 Esophageal cancer MNDR-E-MI-03870
MNDR hsa-miR-107 Esophageal cancer MNDR-E-MI-03871
MNDR hsa-miR-107 Liver cirrhosis MNDR-E-MI-03872
MNDR hsa-miR-107 Lung small cell carcinoma MNDR-E-MI-03873
MNDR hsa-miR-107 Schizophrenia MNDR-E-MI-03874
MNDR hsa-miR-107 Variant creutzfeldt-jakob disease MNDR-E-MI-03875
MNDR hsa-miR-107 Synovial sarcoma MNDR-E-MI-03876
MNDR hsa-mir-107 Head and neck squamous cell carcinoma MNDR-E-MI-03877
MNDR hsa-miR-107 Head and neck squamous cell carcinoma MNDR-E-MI-03878
MNDR hsa-miR-107 T acute lymphoblastic leukemia MNDR-E-MI-03879
MNDR hsa-miR-107 Acute t cell leukemia MNDR-E-MI-03880
MNDR hsa-mir-107 Myocardial infarction MNDR-E-MI-03881
MNDR hsa-mir-107 Heart failure MNDR-E-MI-03882
MNDR hsa-miR-107 Growth hormone-secreting pituitary adenoma MNDR-E-MI-03883
MNDR hsa-miR-107 Fibromyalgia MNDR-E-MI-03884
MNDR hsa-mir-107 Fibromyalgia MNDR-E-MI-03885
MNDR hsa-miR-107 Adenoma MNDR-E-MI-03886
MNDR hsa-miR-107 Breast invasive carcinoma MNDR-E-MI-03887
MNDR hsa-mir-107 Carcinoma hepatocellular MNDR-E-MI-03888
MNDR hsa-miR-107 Hepatocellular carcinoma MNDR-E-MI-03889
MNDR hsa-miR-107 Familiar ovarian carcinoma MNDR-E-MI-03890
MNDR hsa-miR-107 B-cell lymphoma MNDR-E-MI-03891
MNDR hsa-miR-107 Rheumatoid arthritis MNDR-E-MI-03892
MNDR hsa-miR-107 T-cell leukemia MNDR-E-MI-03893
MNDR hsa-miR-107 Malignant pleural mesothelioma MNDR-E-MI-03894
MNDR hsa-mir-107 Muscle atrophy MNDR-E-MI-03895
MNDR hsa-mir-107 Neuroblastoma MNDR-E-MI-03896
MNDR hsa-miR-107 Neuroblastoma MNDR-E-MI-03897
MNDR hsa-mir-107 Chronic kidney disease MNDR-E-MI-03898
MNDR hsa-mir-107 Hodgkin lymphoma MNDR-E-MI-03899
MNDR hsa-miR-107 Hodgkin lymphoma MNDR-E-MI-03900
MNDR hsa-miR-107 Burkitt lymphoma MNDR-E-MI-03901
MNDR hsa-mir-107 Crohn disease MNDR-E-MI-03902
MNDR hsa-mir-107 Melanoma cutaneous malignant 2 MNDR-E-MI-03903
MNDR hsa-miR-107 Acute myelocytic leukemia MNDR-E-MI-03904
MNDR hsa-mir-107 Leukemia acute myelogenous MNDR-E-MI-03905
MNDR hsa-mir-107 Colorectal cancer MNDR-E-MI-03906
MNDR hsa-miR-107 Colorectal cancer MNDR-E-MI-03907
MNDR hsa-miR-107 Nasopharynx carcinoma MNDR-E-MI-03908
MNDR hsa-mir-107 Diabetes mellitus type 2 MNDR-E-MI-03909
MNDR hsa-mir-107 Multiple myeloma MNDR-E-MI-03910
MNDR hsa-miR-107 Multiple myeloma MNDR-E-MI-03911
MNDR hsa-miR-107 Acute lymphocytic leukemia MNDR-E-MI-03912
MNDR hsa-mir-107 Obesity MNDR-E-MI-03913
MNDR hsa-mir-107 Childhood obesity MNDR-E-MI-03914
MNDR hsa-mir-107 Esophageal squamous cell carcinoma MNDR-E-MI-03915
MNDR hsa-miR-107 Ependymoma MNDR-E-MI-03916
MNDR hsa-miR-107 Cardiomegaly MNDR-E-MI-03917
MNDR hsa-miR-107 Nasopharyngeal cancer MNDR-E-MI-03918
MNDR hsa-mir-107 Prostatic neoplasms MNDR-E-MI-03919
MNDR hsa-miR-107 Prostatic neoplasms MNDR-E-MI-03920
MNDR hsa-miR-107 Sleep deprivation MNDR-E-MI-03921
MNDR hsa-miR-107 Cerebral hemorrhage traumatic MNDR-E-MI-03922
MNDR hsa-miR-107 Intracranial hemorrhage hypertensive MNDR-E-MI-03923
MNDR hsa-mir-107 Muscular disorders atrophic MNDR-E-MI-03924
MNDR hsa-miR-107 Stroke lacunar MNDR-E-MI-03925
MNDR hsa-miR-107 Non-alcoholic fatty liver disease MNDR-E-MI-03926
MNDR hsa-miR-107 Breast cancer her3+ negative MNDR-E-MI-03927
MNDR hsa-mir-107 Leukemia chronic lymphatic susceptibility MNDR-E-MI-03928
MNDR hsa-miR-107 Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-03929
MNDR hsa-mir-107 Stroke susceptibility MNDR-E-MI-03930
MNDR hsa-miR-107 Tubulovillous adenoma MNDR-E-MI-03931
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABL2 Homo sapiens RR00027142
TOP